Assessment of pharmacological activity and bioavailability of the new derivative 1,3,4-thiadiazole

Introduction: Acexazolamide is a new derivative of 1,3,4-thiadiazole and acexamic acid. Materials and methods: In animal experiments, acute toxicity, pharmacological activity and bioavailability of acexazolamide were evaluated. Anti-inflammatory activity was assessed on the model of formalin edema of paw and cotton pellet granuloma in rats. Assessment of analgesic activity was carried out in a hot plate test in mice, chemical pain stimulation of the peritoneum and inflammatory hyperalgesia in rats. The antipyretic activity of acexazolamide was evaluated in a model of yeast-induced hyperthermia in rats. The anti-burn activity of acexazolamide was evaluated in a thermal skin burn model in rats. Bioavailability of acexazolamide with intragastric administration was determined in rabbits. The content of acetaxazolamide in blood plasma was determined by HPLC-MS/MS method. Results and discussion: DL50 of acexazolamide after intragastric administration to mice was 860.99 (95% CIs, 462.2 to 1259.8) mg/kg. The anti-inflammatory activity of acexazolamide (21.5 mg/kg) with formalin-induced paw edema and fetal granuloma in rats was higher than that of ketoprofen (23.0 mg/kg). ED50 value for analgesic activity with acetic acid induced cortex was 24.99 (95% CIs: 15.31–34.68) mg/kg. With thermal stimulation of the paw in mice, the ED50 value was 25.56 (95% CIs: 15.13 to 35.98) mg/kg. ED50 value for antipyretic activity was 31.85 (95% CIs: 19.22–44.47) mg/kg. Acexazolamide (21.5 mg/kg) had a stimulating effect on the regeneration of damaged tissues in case of thermal skin burns. Bioavailability of acexazolamide (1 mg/kg) with intragastric administration was 37%. Conclusion: Acexazolamide has the properties of a non-steroidal anti-inflammatory agent.

[1]  Ashutosh Kumar Singh,et al.  Novel 1,3,4-thiadiazoles inhibit colorectal cancer via blockade of IL-6/COX-2 mediated JAK2/STAT3 signals as evidenced through data-based mathematical modeling. , 2019, Cytokine.

[2]  L. Saso,et al.  In vitro antioxidant activity of thiazolidinone derivatives of 1,3-thiazole and 1,3,4-thiadiazole. , 2018, Chemico-biological interactions.

[3]  A. S. Malygin,et al.  LIQUID CHROMATOGRAPHY-TANDEM MASS SPECTROMETRY (HPLS-MS-MS) AS METHOD FOR SEPARATION AND IDENTIFICATION OF NEW ANTI-INFLAMMATORY AGENT FROM DERIVATIVES OF THIADIAZOLILAMIDE , 2018 .

[4]  C. Supuran,et al.  Synthesis of novel 5-amino-1,3,4-thiadiazole-2-sulfonamide containing acridine sulfonamide/carboxamide compounds and investigation of their inhibition effects on human carbonic anhydrase I, II, IV and VII. , 2018, Bioorganic chemistry.

[5]  Á. Lanas,et al.  Mechanisms of Damage to the Gastrointestinal Tract From Nonsteroidal Anti-Inflammatory Drugs. , 2017, Gastroenterology.

[6]  William S Weintraub,et al.  Safety of non-steroidal anti-inflammatory drugs , 2017, European heart journal.

[7]  Wei Xue,et al.  Synthesis and biological activity of myricetin derivatives containing 1,3,4-thiadiazole scaffold , 2017, Chemistry Central Journal.

[8]  M. Montès,et al.  Update on COX-2 Selective Inhibitors: Chemical Classification, Side Effects and their Use in Cancers and Neuronal Diseases. , 2017, Current topics in medicinal chemistry.

[9]  T. Grosser,et al.  The Cardiovascular Pharmacology of Nonsteroidal Anti-Inflammatory Drugs. , 2017, Trends in pharmacological sciences.

[10]  C. Serhan.  Treating inflammation and infection in the 21st century: new hints from decoding resolution mediators and mechanisms , 2017, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[11]  Y. Mabkhot,et al.  A facile synthesis and anticancer activity of some novel thiazoles carrying 1,3,4-thiadiazole moiety , 2017, Chemistry Central Journal.

[12]  A. Aliabadi,et al.  Synthesis and Biological Evaluation of N-(5-(pyridin-2-yl)-1,3,4-thiadiazol-2-yl)benzamide Derivatives as Lipoxygenase Inhibitor with Potential Anticancer Activity , 2017, Iranian journal of pharmaceutical research : IJPR.

[13]  Piyoosh Sharma,et al.  Design, synthesis, evaluation and molecular modelling studies of some novel 5,6-diphenyl-1,2,4-triazin-3(2H)-ones bearing five-member heterocyclic moieties as potential COX-2 inhibitors: A hybrid pharmacophore approach. , 2016, Bioorganic chemistry.

[14]  Ö. Can,et al.  Synthesis and Evaluation of New 1,3,4-Thiadiazole Derivatives as Antinociceptive Agents , 2016, Molecules.

[15]  Sujeet Kumar,et al.  SYNTHESIS AND ANTIINFLAMMATORY ACTIVITY OF SOME IMIDAZO[2,1-b][1,3,4]THIADIAZOLE DERIVATIVES. , 2015, Acta Poloniae Pharmaceutica - Drug Research.

[16]  H. Nadri,et al.  Phthalimide analogs as probable 15-lipoxygenase-1 inhibitors: synthesis, biological evaluation and docking studies , 2015, DARU Journal of Pharmaceutical Sciences.

[17]  J. Matysiak.  Biological and pharmacological activities of 1,3,4-thiadiazole based compounds. , 2015, Mini reviews in medicinal chemistry.

[18]  H. Hamid,et al.  1,3,4-Thiadiazoles: a potent multi targeted pharmacological scaffold. , 2015, European journal of medicinal chemistry.

[19]  Desh Deepak Pandey,et al.  Synthesis, characterization, antimicrobial, and pharmacological evaluation of some 2, 5-disubstituted sulfonyl amino 1,3,4-oxadiazole and 2-amino-disubstituted 1,3,4-thiadiazole derivatives , 2014, Journal of advanced pharmaceutical technology & research.

[20]  Yoon G. Kim,et al.  Development and Validation of a Liquid Chromatography-Tandem Mass Spectrometry Method for the Determination of ε-Acetamidocaproic Acid in Rat Plasma , 2013, Toxicological Research.

[21]  J. Sainy,et al.  2-Amino-5-sulfanyl-1,3,4-thiadiazoles: A new series of selective cyclooxygenase-2 inhibitors , 2008, Acta pharmaceutica.

[22]  M. Østensen.  Safety of non-steroidal anti-inflammatory drugs during pregnancy and lactation , 1996, InflammoPharmacology.

[23]  K. Peace,et al.  Assessment of Pharmacological Activity , 1988 .